Longitudinal analysis of gene expression in porcine skeletal muscle after post-injection local injury

Pharmaceutical Research

Volumn 24, Issue 8, 2007, Pages 1480-1489

  Ferré, Pierre J ^a   Liaubet, Laurence ^b   Concordet, Didier ^a   SanCristobal, Magali ^b   Uro Coste, Emmanuelle ^c   Tosser Klopp, Gwenola ^b   Bonnet, Agnès ^b   Toutain, Pierre Louis ^a   Hatey, François ^b   Lefebvre, Hervé P ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CEMAGREF   (France)

^c INSERM   (France)

Author keywords

Gene expression profiling; Injury; Intramuscular injection; Local tolerance; Pathophysiology

Indexed keywords

ANKYRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COMPLEMENTARY DNA; FIBRONECTIN; GELATINASE A; GUANINE NUCLEOTIDE BINDING PROTEIN; NYLON; OSTEONECTIN; PROPYLENE GLYCOL; RNA; THYMOSIN BETA4;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; EUTHANASIA; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; LONGITUDINAL STUDY; MALE; MICROSCOPY; MUSCLE INJURY; MUSCLE REGENERATION; MYOSITIS; NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RNA ISOLATION; SKELETAL MUSCLE; SWINE;

ANIMALS; COLLAGEN; COLLAGEN TYPE I; DOWN-REGULATION; FIBRONECTINS; GENE EXPRESSION PROFILING; INJECTIONS, INTRAMUSCULAR; MALE; MATRIX METALLOPROTEINASE 2; MUSCLE PROTEINS; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEONECTIN; RAS PROTEINS; SWINE; THYMOSIN; TIME FACTORS; UP-REGULATION;

EID: 34250852303     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9266-8     Document Type: Article

References (36)

1. L. F. Hill. Sites for intramuscular injections. J. Pediatr. 70:158-159 (1967).
2. D. J. Greenblatt, and M. D. Allen. Intramuscular injection-site complications. Jama 240:542-544 (1978).
3. P. C. Beecroft, and S. Redick. Possible complications of intramuscular injections on the pediatric unit. Pediatr. Nurs. 15:333-336 (1989).
4. E. V. Alvarez, M. Munters, L. S. Lavine, H. Manes, and J. Waxman. Quadriceps myofibrosis. A complication of intramuscular injections. J. Bone Joint Surg. Am. 62:58-60 (1980).
5. S. S. Babhulkar. Triceps contracture caused by injections. A report of 11 cases. J. Bone Joint Surg. Br. 67:94-96 (1985).
6. P. S. Bergeson, S. A. Singer, and A. M. Kaplan. Intramuscular injections in children. Pediatrics 70:944-948 (1982).
7. L. Rossi, and D. Conen. Intramuscular injections-an outdated form of administration? 6 cases of Staphylococcus aureus sepsis following intramuscular injections. Schweiz. Med. Wochensch. 125:1477-1482 (1995).
8. R. K. Gherardi, M. Coquet, P. Cherin, L. Belec, P. Moretto, P. A. Dreyfus, J. F. Pellissier, P. Chariot, and F. J. Authier. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 124:1821-1831 (2001).
9. J. G. Tidball. Inflammatory processes in muscle injury and repair. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288:R345-R353 (2005).
10. P. J. Ferre, E. Thein, I. Raymond-Letron, P. L. Toutain, and H. P. Lefebvre. Acute changes in muscle blood flow and concomitant muscle damage after an intramuscular administration. Pharm. Res. 22:405-412 (2005).
11. F. Mottu, A. Laurent, D. A. Rufenacht, and E. Doelker. Organic solvents for pharmaceutical parenterals and embolic liquids: a review of toxicity data. PDA J. Pharm. Sci. Technol. 54:456-469 (2000).
12. G. A. Brazeau, and H. L. Fung. Mechanisms of creatine kinase release from isolated rat skeletal muscles damaged by propylene glycol and ethanol. J. Pharm. Sci. 79:393-397 (1990).
13. S. C. Fahrenkrug, T. P. Smith, B. A. Freking, J. Cho, J. White, J. Vallet, T. Wise, G. Rohrer, G. Pertea, R. Sultana, J. Quackenbush, and J. W. Keele. Porcine gene discovery by normalized cDNA-library sequencing and EST cluster assembly. Mamm. Genome 13:475-478 (2002).
14. A. Brazma, P. Hingamp, J. Quackenbush, G. Sherlock, P. Spellman, C. Stoeckert, J. Aach, W. Ansorge, C. A. Ball, H. C. Causton, T. Gaasterland, P. Glenisson, F. C. Holstege, I. F. Kim, V. Markowitz, J. C. Matese, H. Parkinson, A. Robinson, U. Sarkans, S. Schulze-Kremer, J. Stewart, R. Taylor, J. Vilo, and M. Vingron. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 29:365-371 (2001).
15. F. Lopez, J. Rougemont, B. Loriod, A. Bourgeois, L. Loi, F. Bertucci, P. Hingamp, R. Houlgatte, and S. Granjeaud. Feature extraction and signal processing for nylon DNA microarrays. BMC Genomics 5:38 (2004).
16. L. Breiman. Random forests. Mac. Learn. 45:5-32 (2001).
17. D. B. Seligson, S. Horvath, T. Shi, H. Yu, S. Tze, M. Grunstein, and S. K. Kurdistani. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435:1262-1266 (2005).
18. R. Diaz-Uriarte, and S. Alvarez de Andres. Gene selection and classification of microarray data using random forest. BMC Bioinformatics 7:3 (2006).
19. L. H. Saal, C. Troein, J. Vallon-Christersson, S. Gruvberger, A. Borg, and C. Peterson. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome. Biol. 3:SOFTWARE0003 (2002).
20. W. G. Campbell, S. E. Gordon, C. J. Carlson, J. S. Pattison, M. T. Hamilton, and F. W. Booth. Differential global gene expression in red and white skeletal muscle. Am. J. Physiol. Cell Physiol. 280:C763-C768 (2001).
21. Q. Bai, C. McGillivray, N. da Costa, S. Dornan, G. Evans, M. J. Stear, and K. C. Chang. Development of a porcine skeletal muscle cDNA microarray: analysis of differential transcript expression in phenotypically distinct muscles. BMC Genomics 4:8 (2003).
22. K. Sudre, C. Leroux, G. Pietu, I. Cassar-Malek, E. Petit, A. Listrat, C. Auffray, B. Picard, P. Martin, and J. F. Hocquette. Transcriptome analysis of two bovine muscles during ontogenesis. J. Biochem. (Tokyo) 133:745-756 (2003).
23. M. Summan, M. McKinstry, G. L. Warren, T. Hulderman, D. Mishra, K. Brumbaugh, M. I. Luster, and P. P. Simeonova. Inflammatory mediators and skeletal muscle injury: a DNA microarray analysis. J. Interferon. Cytokine Res. 23:237-245 (2003).
24. G. A. Brazeau, and H. L. Fung. Use of an in vitro model for the assessment of muscle damage from intramuscular injections: in vitro-in vivo correlation and predictability with mixed solvent systems. Pharm. Res. 6:766-771 (1989).
25. T. Hurme, H. Kalimo, M. Lehto, and M. Jarvinen. Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. Med. Sci. Sports Exerc. 23:801-810 (1991).
26. H. P. Lefebvre, V. Laroute, J. P. Braun, V. Lassourd, and P. L. Toutain. Non-invasive and quantitative evaluation of post-injection muscle damage by pharmacokinetic analysis of creatine kinase release. Vet. Res. 27:343-361 (1996).
27. P. J. Ferre, D. Concordet, V. Laroute, G. P. Chanoit, J. P. Ferre, M. Manesse, and H. P. Lefebvre. Comparison of ultrasonography and pharmacokinetic analysis of creatine kinase release for quantitative assessment of postinjection muscle damage in sheep. Am. J. Vet. Res. 62:1698-1705 (2001).
28. A. Ishii, and S. H. Lo. A role of tensin in skeletal-muscle regeneration. Biochem. J. 356:737-745 (2001).
29. C. Bean, M. Salamon, A. Raffaello, S. Campanaro, A. Pallavicini, and G. Lanfranchi. The Ankrd2, Cdkn1c and calcyclin genes are under the control of MyoD during myogenic differentiation. J. Mol. Biol. 349:349-366 (2005).
30. S. Kojic, E. Medeot, E. Guccione, H. Krmac, I. Zara, V. Martinelli, G. Valle, and G. Faulkner. The Ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J. Mol. Biol. 339:313-325 (2004).
31. A. Pallavicini, S. Kojic, C. Bean, M. Vainzof, M. Salamon, C. Ievolella, G. Bortoletto, B. Pacchioni, M. Zatz, G. Lanfranchi, G. Faulkner, and G. Valle. Characterization of human skeletal muscle Ankrd2. Biochem. Biophys. Res. Commun. 285:378-386 (2001).
32. A. D. Bradshaw, and E. H. Sage. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 107:1049-1054 (2001).
33. R. A. Brekken, and E. H. Sage. SPARC, a matricellular protein: at the crossroads of cell-matrix. Matrix Biol. 19:569-580 (2000).
34. C. Strup-Perrot, D. Mathe, C. Linard, D. Violot, F. Milliat, A. Francois, J. Bourhis, and M. C. Vozenin-Brotons. Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am. J. Physiol. Gastrointest. Liver Physiol. 287:G875-G885 (2004).
35. J. D. Young, A. J. Lawrence, A. G. MacLean, B. P. Leung, I. B. McInnes, B. Canas, D. J. Pappin, and R. D. Stevenson. Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids. Nat. Med. 5:1424-1427 (1999).
36. K. M. Malinda, G. S. Sidhu, H. Mani, K. Banaudha, R. K. Maheshwari, A. L. Goldstein, and H. K. Kleinman. Thymosin beta4 accelerates wound healing. J. Invest. Dermatol. 113:364-368 (1999).